You just read:

Evofem Biosciences Announces Last Patient Enrolled for AMPREVENCE, the Phase 2b Sexually Transmitted Infections Trial of Amphora

News provided by

Evofem Biosciences, Inc.

Apr 23, 2019, 08:11 ET